Actively Recruiting
Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)
Led by Synchrony-Medical, Ltd · Updated on 2026-04-13
200
Participants Needed
3
Research Sites
75 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to collect data to assess the use of the LibAirty™ System for improving bronchiectasis symptoms and healthcare resource utilization when it is used at home. The main question this study is trying to answer is: How often do adults with bronchiectasis experience pulmonary exacerbations (flare-ups of their lung condition) while using the LibAirty™ airway clearance system at home? Participants will use the LibAirty™ airway clearance system at home as prescribed by their doctor - the device is not being provided as part of the study. The study will last for 12 months from the time participants begin using LibAirty. During the study period, participants will continue with their usual clinic visits. At some of these regular visits (up to 4 times over the year), participants will be asked to complete short questionnaires about their bronchiectasis symptoms and their experience using LibAirty. At these same visits, the study team will also review participants' medical records and collect information related to their bronchiectasis condition, such as test results, medications, and any hospital or emergency room visits.
CONDITIONS
Official Title
Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a radiological diagnosis of Bronchiectasis based on high resolution chest CT scan
- Have bronchiectasis with either daily productive cough or two or more pulmonary exacerbations needing antibiotics in the last 12 months
- Be at least 21 years old
- Be prescribed and receive the LibAirty system for home use
- Be on a standard care plan with at least one doctor visit every 6 months
- Have had no change in bronchiectasis treatment in the 2 months before enrollment
- Provide signed informed consent
You will not qualify if you...
- Unable to use the LibAirty system independently as directed
- Any condition that may risk participant safety or affect study results as judged by the principal investigator
- Pregnancy or planned pregnancy during the 12-month study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
Actively Recruiting
2
Emory University School Of Medicine
Atlanta, Georgia, United States, 30342
Actively Recruiting
3
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here